Roundup weedkiller cancer trials now trending Bayer’s way

Bayer on [March 5] said it won a trial in a lawsuit brought by a retired postal service worker in Pennsylvania who alleged he developed non-Hodgkins lymphoma from using the company’s Roundup weedkiller.

In addition to the jury verdict in the Philadelphia Court of Common Pleas, Bayer said a California farmer, who said he contracted the same type of cancer from exposure to the product, and his wife on [March 5] voluntarily dropped their lawsuit while a trial was underway in the in state court in Sonoma County, California.

[The March 5] victories come on the heels of another trial win for the company in Arkansas on [March 1]. Bayer has now prevailed in 13 of the last 20 Roundup trials, while plaintiffs have scored large verdicts totaling more than $4 billion, including $2.25 billion in a single case in January.

Related on the SLP

Facing mounting number of glyphosate lawsuits, Bayer offers 5-point plan to address future Roundup weedkiller claims Roundup litigation reprieve? U.S. government backs Bayer’s claim that its glyphosate is safe-as-used finding preempts random, conflicting state-by-state ‘failure-to-warn’ claims

Viewpoint: America Last: From the Pentagon to universities, Trump’s corruption of science could inflict lasting, irreversible damage on U.S. research

Helpful until we’re helpless? Researchers warn AI is gradually eroding human control

‘Silent killer’: Hepatitis B could surge under Trump–RFK Jr. rollback of newborn vaccine recommendations

The company is appealing its trial losses, which include large punitive damages awards that are likely to be reduced because they exceed U.S. Supreme Court guidance.

This is an excerpt. Read the original post here